Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Susan L. Albert, M.D.
Family Practice · NORTH WILKESBORO, NC · NPI 1578597670
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Furosemide | Furosemide | 427 | 58 |
| Levothyroxine Sodium | Levothyroxine Sodium | 382 | 48 |
| Memantine Hcl | Memantine Hcl | 377 | 46 |
| Omeprazole | Omeprazole | 356 | 55 |
| Atorvastatin Calcium | Atorvastatin Calcium | 281 | 39 |
| Amlodipine Besylate | Amlodipine Besylate | 277 | 42 |
| Metoprolol Tartrate | Metoprolol Tartrate | 259 | 30 |
| Pantoprazole Sodium | Pantoprazole Sodium | 244 | 33 |
| Lisinopril | Lisinopril | 242 | 33 |
| Escitalopram Oxalate | Escitalopram Oxalate | 240 | 30 |
| Sertraline Hcl | Sertraline Hcl | 214 | 30 |
| Losartan Potassium | Losartan Potassium | 199 | 25 |
| Spironolactone | Spironolactone | 189 | 30 |
| Eliquis | Apixaban | 163 | 29 |
| Mirtazapine | Mirtazapine | 157 | 29 |
| Gabapentin | Gabapentin | 151 | 26 |
| Lorazepam | Lorazepam | 150 | 38 |
| Donepezil Hcl | Donepezil Hcl | 149 | 24 |
| Metoprolol Succinate | Metoprolol Succinate | 141 | 16 |
| Potassium Chloride | Potassium Chloride | 131 | 29 |
| Quetiapine Fumarate | Quetiapine Fumarate | 131 | 18 |
| Buspirone Hcl | Buspirone Hcl | 128 | 20 |
| Oxycodone Hcl | Oxycodone Hcl | 124 | 32 |
| Warfarin Sodium | Warfarin Sodium | 121 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 106 | 17 |
| Alendronate Sodium | Alendronate Sodium | 99 | 13 |
| Metformin Hcl | Metformin Hcl | 98 | 14 |
| Carvedilol | Carvedilol | 92 | 15 |
| Clopidogrel | Clopidogrel Bisulfate | 86 | 12 |
| Jardiance | Empagliflozin | 85 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 79 | 13 |
| Divalproex Sodium | Divalproex Sodium | 78 | 15 |
| Nystatin | Nystatin | 76 | 27 |
| Montelukast Sodium | Montelukast Sodium | 71 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 70 | 11 |
| Ipratropium Bromide | Ipratropium Bromide | 67 | 12 |
| Lactulose | Lactulose | 67 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 66 | 34 |
| Prednisone | Prednisone | 66 | 22 |
| Metformin Hcl Er | Metformin Hcl | 64 | suppressed |
| Allopurinol | Allopurinol | 61 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 58 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 58 | 56 |
| Ozempic | Semaglutide | 58 | suppressed |
| Hydrocortisone | Hydrocortisone | 53 | 25 |
| Januvia | Sitagliptin Phosphate | 52 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 52 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 52 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 49 | 12 |
| Meclizine Hcl | Meclizine Hcl | 48 | 19 |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 47 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 46 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 46 | 34 |
| Humalog | Insulin Lispro | 45 | suppressed |
| Mupirocin | Mupirocin | 44 | 24 |
| Rivastigmine | Rivastigmine Tartrate | 44 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 41 | suppressed |
| Pregabalin | Pregabalin | 41 | suppressed |
| Famotidine | Famotidine | 39 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 39 | suppressed |
| Cephalexin | Cephalexin | 38 | 25 |
| Lamotrigine | Lamotrigine | 38 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 38 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 37 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 36 | 26 |
| Erythromycin | Erythromycin Base | 36 | 11 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 34 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 33 | suppressed |
| Rivastigmine | Rivastigmine | 33 | suppressed |
| Baclofen | Baclofen | 32 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 32 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 32 | 24 |
| Linzess | Linaclotide | 31 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 30 | suppressed |
| Finasteride | Finasteride | 29 | suppressed |
| Latanoprost | Latanoprost | 29 | suppressed |
| Sodium Chloride | Sodium Chloride Irrig Solution | 28 | 17 |
| Pioglitazone Hcl | Pioglitazone Hcl | 27 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 27 | suppressed |
| Xarelto | Rivaroxaban | 27 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 26 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 26 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 25 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 25 | suppressed |
| Alprazolam | Alprazolam | 24 | suppressed |
| Risperidone | Risperidone | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 23 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Levofloxacin | Levofloxacin | 22 | 20 |
| Trulicity | Dulaglutide | 22 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 21 | suppressed |
| Bumetanide | Bumetanide | 21 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 20 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 20 | suppressed |
| Clonazepam | Clonazepam | 20 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 20 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 20 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 20 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 19 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 18 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Restasis | Cyclosporine | 17 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | suppressed |
| Cefdinir | Cefdinir | 15 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 15 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 14 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | 11 |
| Topiramate | Topiramate | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Carbamazepine Er | Carbamazepine | 13 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Entecavir | Entecavir | 13 | suppressed |
| Ezetimibe | Ezetimibe | 13 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Leflunomide | Leflunomide | 13 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 13 | suppressed |
| Mercaptopurine | Mercaptopurine | 13 | suppressed |
| Methotrexate | Methotrexate Sodium | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Novolog | Insulin Aspart | 13 | suppressed |
| Synthroid | Levothyroxine Sodium | 13 | suppressed |
| Azathioprine | Azathioprine | 12 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 12 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 11 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Dupixent Syringe | Dupilumab | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Xifaxan | Rifaximin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error